Key facts
- Notable investors include Summit Partners, JSL Health Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for RIS Rx
- ·The full record, as it builds
Funding rounds
No funding rounds for RIS Rx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RIS Rx
Operator of a healthcare and loyalty program solutions organization, intended to improve health and wellness for all. The company's services provide technology-infused, comprehensive pharmacy HUB services that are distinguished by a high standard of proficiency, efficiency, and innovation, enabling patients to get and stay on therapy with uncompromising effort.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2020
- Employees
- 54
- Website
- risrx.com/
- Ownership
- Privately Held (backing)
RIS Rx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RIS Rx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RIS Rx in its N-PORT filings yet. We sweep new filings monthly.